Clinical trial
A Randomised, Double-Blind Study of Pravastatin for the Treatment of Hyperlipidaemia in Patients With HIV
NCT00227500 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Double-Blind Study of Pravastatin for the Treatment of Hyperlipidaemia in Patients With HIV
- Lead sponsor
- Kirby Institute
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2001
- Completion date
- October 31, 2004
- Enrollment
- 40
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular disease, glucose metabolism, hiv infections, lipid metabolism, lipodystrophy, metabolic abnormality